2 German cities to launch adult-use cannabis sales pilot project in 2025
A limited number of residents of two German cities will be allowed to buy legal adult-use cannabis in a five-year pilot launching in 2025.
A limited number of residents of two German cities will be allowed to buy legal adult-use cannabis in a five-year pilot launching in 2025.
Medical cannabis sales in Germany are on pace to exceed a record 420 million euros (roughly $455.2 million) in 2024, a new report shows.
Medical marijuana company IM Cannabis Corp. is planning a non-brokered private placement offering of up to $1.6 million through the sale of about 625,000 units.
The number of applications and licenses granted for cannabis cultivation social clubs in Germany continued to grow throughout September, but growth has slowed month-over-month.
Germany’s long-anticipated “Pillar 2,” which would launch adult-use marijuana sales as part of a limited-duration pilot project, is in danger of being abandoned, according to elected officials.
Cannabis operator Flora Growth Corp. announced an agreement with London-based Blossom Genetics to supply medical marijuana to the German market.
Increased consumer demand for American cannabis products and emerging opportunities in Europe are driving some U.S. brands to expand internationally.